YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF)
YIHCF Stock Price Chart
Explore YiChang HEC ChangJiang Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze YIHCF price movements and trends.
YIHCF Company Profile
Discover essential business fundamentals and corporate details for YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (YIHCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Sept 2021
Employees
4.62K
Website
https://cj.hec.cnCEO
Juncai Jiang
Description
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
YIHCF Financial Timeline
Browse a chronological timeline of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Mar 2026
Earnings released on 28 Aug 2025
Earnings released on 28 Mar 2025
EPS came in at -$0.03 , while revenue for the quarter reached $173.81M .
Earnings released on 30 Aug 2024
EPS came in at $0.11 , while revenue for the quarter reached $337.80M .
Earnings released on 7 Jun 2024
EPS came in at $0.15 , while revenue for the quarter reached $435.66M .
Dividend declared on 10 May 2024
A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend will be paid on 31 Oct 2025.
Earnings released on 30 Jun 2023
EPS came in at $0.16 , while revenue for the quarter reached $442.92M .
Earnings released on 24 Mar 2023
EPS came in at $0.02 falling short of the estimated $0.03 by -47.79%, while revenue for the quarter reached $358.08M , beating expectations by +200.25%.
Earnings released on 26 Aug 2022
EPS came in at -$0.01 , while revenue for the quarter reached $192.97M .
Earnings released on 21 Mar 2022
EPS came in at -$0.01 , while revenue for the quarter reached $111.73M .
Earnings released on 22 Sept 2021
EPS came in at -$0.09 , while revenue for the quarter reached $31.27M .
Earnings released on 19 Mar 2021
EPS came in at $0.03 , while revenue for the quarter reached $40.50M .
Earnings released on 30 Oct 2020
EPS came in at $0.08 , while revenue for the quarter reached $295.11M .
Dividend declared on 21 Aug 2020
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 16 Nov 2020.
YIHCF Stock Performance
Access detailed YIHCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.